Mj. Sheardown et Ljs. Knutsen, UNEXPECTED NEUROPROTECTION OBSERVED WITH THE ADENOSINE A(2A) RECEPTORAGONIST CGS-21680, Drug development research, 39(1), 1996, pp. 108-114
The selective adenosine A(2A) receptor agonists )phenylethylamino]-5'-
N-ethylcarboxyamidoadenosine (CGS 21680), N-[2-(3,5-dimethoxyphenyl)et
hyl]adenosine (DPMA) and metrifudil were investigated for their abilit
y to prevent the loss of pyramidal CA1 neurons in the hippocampus foll
owing 5 min of severe temporary forebrain ischemia in mongolian gerbil
s. CGS 21680, when administered at 18.7 mu mol/kg 30 and 120 min follo
wing reperfusion, exhibited highly significant protection against neur
onal loss, but was inactive at 5.6 mu mol/kg. DPMA, a more potent agon
ist at A(1) and A(2A) receptors, was inactive up to a dose of 19 mu mo
l/kg. Metrifudil (equipotent with CGS 21680 at A(2A) > 25 times more p
otent at A(1)) gave a modest degree of protection at 26 mu mol/kg and
was inactive at 7.8 mu mol/kg. CCS 21680 showed an equal degree of hyp
othermia at 5.6 and 18.7 mu mol/kg, suggesting that this was not the p
rime mode of action. While the effect of metrifudil may be the result
of its higher A(1) receptor affinity, the mode of action of CCS 21680
has not been established; the data, however, suggest that a non-A(1) n
on-A(2A) receptor mechanism may possibly be involved. (C) 1997 Wiley-L
iss, Inc.